Author + information
- Geetanjali Danga,b,
- Susan Oleta,b,
- Muhammad Shahreyara,b,
- Nasir Sulemanjeea,b,
- Khwaja Ammara,b,
- Indrajit Choudhuria,b,
- Imran Niazia,b,
- Jasbir Sraa,b,
- A. Jamil Tajika,b and
- Arshad Jahangira,b
Background: CHA2DS2VASc scoring system is a useful clinical tool to characterize stroke risk in patients with and without atrial Fibrillation (AF), yet thromboembolic complications occur in patients deemed low risk for stroke (0-1 score for AF and 0-3 score for non-AF patients). We hypothesized that incorporating information about renal dysfunction will improve risk stratification of patients with CHA2DS2VASc score of 0 to 3.
Methods: Consecutive patients with or without AF evaluated at a large community based academic medical center from 2012 to 2015 were identified and those with a CHA2DS2VASc Score of 0-3 assessed for incident stroke. Based on estimated glomerular filtration rate (eGFR) relative improvement in risk stratification of stroke in AF and non-AF patients were determined using cochrane armitage test.
Results: The overall proportion of stroke over 3 years mean follow-up in patients with or without AF with baseline CHA2DS2VASc score 0-3 with eGFR and improvement in risk stratification is summarized in Table.
Conclusions: In patients considered low risk by CHA2DS2VASc score, incorporating eGFR information improves risk stratification and decision for anticoagulation.
Poster Hall, Hall C
Saturday, March 18, 2017, 3:45 p.m.-4:30 p.m.
Session Title: Innovative Approaches for Reducing Risk and Improving Outcomes With Ablation
Abstract Category: 8. Arrhythmias and Clinical EP: Supraventricular/Ventricular Arrhythmias
Presentation Number: 1237-106
- 2017 American College of Cardiology Foundation